Earkart IPO
Live Updates, GMP, Subscription Data, and Financial Details
IPO Overview
Listed
Dates
Sep 25 to Sep 29 2025
Price Band
₹135
Current GMP
₹135.5 (+0.37%)
Subscription
1.28 times
IPO Details
| IPO Date | September 25, 2025 to September 29, 2025 |
| Listing Date | [.] |
| Face Value | ₹10 per share |
| Issue Price Final | ₹135 per share |
| Lot Size | 1,000 Shares |
| Sale Type | Fresh Capital-cum-Offer for Sale |
| Total Issue Size | 36,49,000 shares (aggregating up to ₹49.26 Cr) |
| Reserved for Market Maker | 1,85,000 shares (aggregating up to ₹2.50 Cr)Rikhav Securities Ltd. |
| Fresh Issue (Ex Market Maker) | 31,30,000 shares (aggregating up to ₹42.26 Cr) |
| Offer for Sale | 3,34,000 shares of ₹10 (aggregating up to ₹4.51 Cr) |
| Net Offered to Public | 34,64,000 shares (aggregating up to ₹46.76 Cr) |
| Issue Type | Fixed Price IPO |
| Listing At | BSE SME |
| Share Holding Pre Issue | 1,04,38,932 shares |
| Share Holding Post Issue | 1,37,53,932 shares |
IPO Date
September 25, 2025 to September 29, 2025
Listing Date
[.]
Face Value
₹10 per share
Issue Price Final
₹135 per share
Lot Size
1,000 Shares
Sale Type
Fresh Capital-cum-Offer for Sale
Total Issue Size
36,49,000 shares (aggregating up to ₹49.26 Cr)
Reserved for Market Maker
1,85,000 shares (aggregating up to ₹2.50 Cr)Rikhav Securities Ltd.
Fresh Issue (Ex Market Maker)
31,30,000 shares (aggregating up to ₹42.26 Cr)
Offer for Sale
3,34,000 shares of ₹10 (aggregating up to ₹4.51 Cr)
Net Offered to Public
34,64,000 shares (aggregating up to ₹46.76 Cr)
Issue Type
Fixed Price IPO
Listing At
BSE SME
Share Holding Pre Issue
1,04,38,932 shares
Share Holding Post Issue
1,37,53,932 shares
IPO Subscription Details
| Market Maker | 1 |
| Non-Institutional Buyers*** | 1.63 |
| Individual Investors (IND category bidding for 2 Lots) | 0.35 |
| Total ** | 1.28 |
Market Maker
1
Non-Institutional Buyers***
1.63
Individual Investors (IND category bidding for 2 Lots)
0.35
Total **
1.28
Day Wise Sub
| Day | NII* | Individual Investors | Total |
|---|---|---|---|
| Day 1 Sep 25, 2025 | 0.12 | 0.02 | 0.07 |
| Day 2 Sep 26, 2025 | 0.04 | 0.04 | 0.04 |
| Day 3 Sep 29, 2025 | 1.63 | 0.35 | 1.28 |
DayDay 1
Sep 25, 2025
NII*0.12
Individual Investors0.02
Total0.07
DayDay 2
Sep 26, 2025
NII*0.04
Individual Investors0.04
Total0.04
DayDay 3
Sep 29, 2025
NII*1.63
Individual Investors0.35
Total1.28
Day Wise GMP
| Date | Price | GMP | Estimate List Price |
|---|---|---|---|
| 03-10-2025 | 135.00 | 0(0.00%) | 135 |
| 02-10-2025 | 135.00 | 0(0.00%) | 135 |
| 01-10-2025 | 135.00 | 0(0.00%) | 135 |
| 30-09-2025 | 135.00 | 0(0.00%) | 135 |
| 29-09-2025 | 135.00 | 0(0.00%) | 135 |
| 28-09-2025 | 135.00 | 0(0.00%) | 135 |
| 27-09-2025 | 135.00 | 0(0.00%) | 135 |
| 26-09-2025 | 135.00 | 0(0.00%) | 135 |
| 25-09-2025 | 135.00 | 0(0.00%) | 135 |
| 24-09-2025 | 135.00 | 0(0.00%) | 135 |
| 23-09-2025 | 135.00 | 0(0.00%) | 135 |
Date03-10-2025
Price135.00
GMP0(0.00%)
Estimate List Price135
Date02-10-2025
Price135.00
GMP0(0.00%)
Estimate List Price135
Date01-10-2025
Price135.00
GMP0(0.00%)
Estimate List Price135
Date30-09-2025
Price135.00
GMP0(0.00%)
Estimate List Price135
Date29-09-2025
Price135.00
GMP0(0.00%)
Estimate List Price135
Date28-09-2025
Price135.00
GMP0(0.00%)
Estimate List Price135
Date27-09-2025
Price135.00
GMP0(0.00%)
Estimate List Price135
Date26-09-2025
Price135.00
GMP0(0.00%)
Estimate List Price135
Date25-09-2025
Price135.00
GMP0(0.00%)
Estimate List Price135
Date24-09-2025
Price135.00
GMP0(0.00%)
Estimate List Price135
Date23-09-2025
Price135.00
GMP0(0.00%)
Estimate List Price135
IPO Important Dates
| IPO Open Date | Thu, Sep 25, 2025 |
| IPO Close Date | Mon, Sep 29, 2025 |
| Tentative Allotment | Tue, Sep 30, 2025 |
| Initiation of Refunds | Wed, Oct 1, 2025 |
| Credit of Shares to Demat | Wed, Oct 1, 2025 |
| Tentative Listing Date | Fri, Oct 3, 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on Mon, Sep 29, 2025 |
IPO Open Date
Thu, Sep 25, 2025
IPO Close Date
Mon, Sep 29, 2025
Tentative Allotment
Tue, Sep 30, 2025
Initiation of Refunds
Wed, Oct 1, 2025
Credit of Shares to Demat
Wed, Oct 1, 2025
Tentative Listing Date
Fri, Oct 3, 2025
Cut-off time for UPI mandate confirmation
5 PM on Mon, Sep 29, 2025
IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual investors (Retail) (Min) | 2 | 2,000 | ₹2,70,000 |
| Individual investors (Retail) (Max) | 2 | 2,000 | ₹2,70,000 |
| HNI (Min) | 3 | 3,000 | ₹4,05,000 |
ApplicationIndividual investors (Retail) (Min)
Lots2
Shares2,000
Amount₹2,70,000
ApplicationIndividual investors (Retail) (Max)
Lots2
Shares2,000
Amount₹2,70,000
ApplicationHNI (Min)
Lots3
Shares3,000
Amount₹4,05,000
Financial Information
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
| Assets | 30.29 | 19.25 | 14.73 |
| Total Income | 43.19 | 31.97 | 28.97 |
| Profit After Tax | 6.88 | 3.06 | 1.31 |
| EBITDA | 9.76 | 3.55 | 1.61 |
| NET Worth | 19.92 | 13.03 | 6.56 |
| Reserves and Surplus | 9.48 | 12.97 | 6.49 |
| Total Borrowing | 4.96 | 4.00 | 1.21 |
Period EndedPeriod Ended
31 Mar 202531 Mar 2025
31 Mar 202431 Mar 2024
31 Mar 202331 Mar 2023
Period EndedAssets
31 Mar 202530.29
31 Mar 202419.25
31 Mar 202314.73
Period EndedTotal Income
31 Mar 202543.19
31 Mar 202431.97
31 Mar 202328.97
Period EndedProfit After Tax
31 Mar 20256.88
31 Mar 20243.06
31 Mar 20231.31
Period EndedEBITDA
31 Mar 20259.76
31 Mar 20243.55
31 Mar 20231.61
Period EndedNET Worth
31 Mar 202519.92
31 Mar 202413.03
31 Mar 20236.56
Period EndedReserves and Surplus
31 Mar 20259.48
31 Mar 202412.97
31 Mar 20236.49
Period EndedTotal Borrowing
31 Mar 20254.96
31 Mar 20244.00
31 Mar 20231.21
Peers Comparison
| Company Name | EPS (Basic) | P/E (x) | RoNW (%) | Financial statements |
|---|---|---|---|---|
| Earkart Limited | 6.59 | 41.77 | Restated | |
| OSEL Devices Limited | 14.31 | 16.91 | 18.58 | Restated |
Company NameEarkart Limited
EPS (Basic)6.59
P/E (x)
RoNW (%)41.77
Financial statementsRestated
Company NameOSEL Devices Limited
EPS (Basic)14.31
P/E (x)16.91
RoNW (%)18.58
Financial statementsRestated
IPO Reservation
| Market Maker Shares Offered | 1,85,000 (5.07%) |
| NII (HNI) Shares Offered | 17,32,000 (47.47%) |
| Retail Shares Offered | 17,32,000 (47.47%) |
| Total Shares Offered | 36,49,000 (100.00%) |
Market Maker Shares Offered
1,85,000 (5.07%)
NII (HNI) Shares Offered
17,32,000 (47.47%)
Retail Shares Offered
17,32,000 (47.47%)
Total Shares Offered
36,49,000 (100.00%)
Information about company
Earkart Limited is a HealthTech platform, specializing in hearing aids and related accessories. It offers modern hearing devices, like Receiver-In-Canal (RIC), Invisible (IIC), Behind-The-Ear (BTE), In-The-Ear (ITE), In-The-Canal (ITC) and Completely-In-Canal (CIC).
It also offers and distributes other products like adjustable foldable walkers and Multi-Sensory Integrated Educational Development (MSIED) and Teaching Learning Material (TLM) for physically challenged.
The company sells products through a network of partners and clinics, both domestically and globally. It is also a trusted Government e-Market (GeM) supplier of hearing aids to ALIMCO under Ministry of Social Justice and Empowerment.
In April 2024, the company has launched Shop in Shop (SIS) model, wherein it offers franchise to opticians and ENT/optical clinics. As on date, the company operates 49 SIS clinics across 22 cities in 6 states and 2 Union Territories, i.e., Haryana, Uttar Pradesh, Rajasthan, Punjab, Jharkhand, Delhi, Uttarakhand, and Chandigarh.
Its manufacturing facility is located in Noida, across 4,500 square feet
Competitive Strengths:
Various types of hearing aids products
Multi-channel product distribution network: Online, offline, and B2G sales
Continued focus on innovation and technology
Objectives of IPO
The Company Earkart IPO proposes to utilise the Net Proceeds from the Issue towards the following objects:
S.No.
Objects of the Issue
Expected Amount (₹ in crores)
1
Funding incremental working capital requirements of our Company
21.10
2
Funding capital expenditure requirements for setting of Shop in Shop (SIS) Business Model in ENT/Ophthalmic Clinics across India and Setting up of Infrastructure for operational activities
17.33
3
General Corporate Purposes
0.63
Disclaimer
All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on Information published on this application.
No financial information whatsoever published anywhere, within this application, should be considered as advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever
Please read all Tearms and conditions , and agree to use the App